
    
      Patients: consecutively referred for HSC mobilization. At least 17 days after the previous
      chemotherapy. No hematological growth factor during the 8 previous days.

      Mobilization: one sc injection of 300 Âµg/kg pegfilgrastim (Neulasta, Amgen)

      Evaluation during the study: CD34 circulating cells from day 2 to day 7 ; AE recording

      Judgment criterion: percentage of children achieving at least 5x10e6 CD34 cells with a
      standard apheresis (less than 2 blood volume processed)

      Analysis: sequential Bayesian study
    
  